SEC Form 4 · accession 0001209191-15-036223
CLEVELAND BIOLABS INC · CBLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony Principi
Director
Period of report
Apr 22, 2015
Accepted (ET)
Apr 24, 2015 · 7:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001318641
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.20 | Apr 22, 2015 | A | 16,000 | A | Jul 14, 2015 | Apr 22, 2025 | Common Stock | 16,000 | 16,000 | D |
Explanation of responses
- F1The option will become exercisable with respect to 25% of the total shares on July 14, 2015, for 50% of the total shares on October 14, 2015, for 75% of the total shares on January 14, 2016, and 100% of the total shares on April 14, 2016.